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Aim: To assess the long-term safety and efficacy of alcohol septal ablation
(ASA) in young adults.
Methods: Data of 163 consecutive patients who underwent ASA at our
institution from 2000 to 2010 were reviewed. Clinical follow-up was obtained
at a mean of 3 years after ASA in patients aged between 18 and 40 years at
the time of the procedure.
Results: During the study period, 21 patients (15 males) aged between 18
and 40 years old (mean age 33.1±5.6, range 18-39 years) underwent ASA.
Among them, 76% were treated with beta-blockers, 33% calcium-channel
antagonists and 5% disopyramide. There were 6 patients (29%) with prior
pacemaker, 1 patient (5%) with history of sudden death and prior implantable
cardioverter-defibrillator (ICD) and 1 patient (5%) with prior myectomy. At
baseline, mean New York Heart Association (NYHA) functional class was
2.4±0.5. Mean left ventricular outflow tract (LVOT) peak gradient and septal
thickness were 89±37 mmHg and 24.9±5.1 mm, respectively. All procedures
were performed with myocardial contrast echocardiography guidance. During
ASA, 2.2±0.7 ml of absolute alcohol was injected in 1.4±0.5 septal perfora-
tors. Final procedural LVOT peak gradient was 20±16mmHg. Procedural suc-
cess (defined as immediate LVOT peak gradient reduction >50%) was
achieved in 20 patients (95%). There were no major complications. One
patient (5%) required a temporary pacemaker for second-degree atrioventric-
ular block. Mean peak CK was 934±468 IU/L. At a mean follow-up of
3.0±2.0 years after the procedure (range 0.3-8.4), repeat ASA was performed
in two patients (10%) and a new ICD was needed in 1 patient (5%), while
there were no fatalities reported. Mean NYHA class was improved to 1.6±0.7.
Conclusion: ASA in young patients appears to be safe and effective.
Immediate success is achieved in a large majority of patients and procedural
complication rates are low. In addition, 3-year follow-up shows sustained clin-
ical benefit with a low rate of adverse events.
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Background: Tako-tsubo cardiomyopathies (TTC) are usually associated
with emotional or physics stress as aetiological factors. Nonetheless, exposi-
tion to stress does not unconditionally lead to TTC development. We hypoth-
esize that TTC may occur in a predisposed population.
Purpose: The aim of our prospective study was to define the prevalence of
major anxiety troubles in a population of patients with TTC compared with a
population of sex and age matched patients with acute coronary syndrome
with troponin elevation (ACS).
Method: Between January 2010 and March 2011, 35 patients with TTC
confirmed by coronary angiography, cardiac MRI and clinical evolution were
prospectively underwent to the psychiatric MINI test to research new or past
major depressive episode (MDE), generalized anxiety trouble (GAT), post-
traumatic stress state (PTSS) or dysthymia (DT). The same test was realized
in a population of 30 matched patients with ACS.
Results: Mean age was 74 (65.5-82.5) years in the TTC group and 73
(70.2-80.2) in the ACS group (p = 0.484) with 11 % men in each group. There
was no difference between TTC group and ACS group regarding cardiovas-
cular risk factors. Among TTC 29 underwent finally the test (6 exclusion
because of incapacity to understant the test), 16 (55.2%),11 (37.9%), 7
(24.2%), 3 (10.4%) and 1 (3.5%) patients had new MDE, past MDE, GAT,
PTSS and DT respectively. Among the 30 patients with ACS 5 (16.6 %; p
<0.005), 4 (13.3%; p<0.05), 2 (6.6%; p=0.074), 1 (3.3%; p=0.3) and 1 (3.3%;
p=0.9) patient had new MED, past MED, TAG, PTSS and DT respectively.
Major anxiety troubles were found in 19 (65.5%) patients in the TTC group
versus 7 (23.3%) patients in the ACS group (p<0.005).
Conclusion: TTC are more frequently associated with major anxiety trou-
bles and particularly new or past MDE. This association is not present for
PTSS, GAT or DT. These findings suggest that TTC and depression may
share common pathophysiological pathway.
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Peripartum cardiomyopathy (PPCM) is frequent in Africa. It is characterized
by heart failure in the last month of pregnancy or in the 5 months followings
delivery. If the pathogenesis of the disease is still obscure the diagnostic has been
greatly simplified by echocardiography showing typical appearance of hypokinetic
cardiomyopathy, often dilated in a context of early heart failure occurred in the
peripartum. However, manifestations of the disease are not unambiguous and
changing parameters echocardiography has been little studied.
The aim of this work was to assess the echocardiographic abnormalities of
the PPCM and to determine on 12 patients the evolution and the prognostic
factors of this disease. The cases of peripartum cardiomyopathy treated from
January 2008, to January 2011 in our service were reviewed. The abnormali-
ties of the wall motion, constantly found, were diffuse in all patients and local-
ized or prevalent on the interventricular septum or the left ventricular posterior
wall in the other cases. The cardiac chambers were dilated in all patients. The
left ventricular systolic dysfunction was constant. The other abnormalities
were: restrictive mitral profil (6 patients) low mitral and aortic flow (3 cases),
the mitral (10 cases) and tricuspid regurgitation (8). During follow up, all
patients improved to Class I of NYHA, 2 patients improved their echocardio-
graphic parameters and one patient died after a subsequent pregnancy.
The factors associated with the absence of normalization of the echocardio-
graphic parameters were: the gestity, the parity, the cardiothoracic ratio, the
left ventricular volumes, and the parameters of left ventricular function.
In conclusion, symptoms improve over time in a significant numbers of
patients, which is corroborated by improvement of the LV function as
assessed by echocardiography. Certain variables at initial evaluation can help
in identifying high risk subsets with peripartum cardiomyopathy.
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Background: Although numerous patients are suffering from heart failure
with preserved ejection fraction (HFPEF), no specific treatments have been
shown to be efficient so far. We hypothesized that inter-atrial conduction
delay (IACD) associated with a short left atrio-ventricular interval (LAVI)
may impair left ventricular active filling as it reduces the left atrium “kick”
which occurs against the closing mitral valve.
We assessed the clinical efficacy and safety of left atrial pacing therapy as
a new treatment to restore the left ventricular active filling in these patients.
Methods: Six NYHA class III patients with severe HFPEF and no other
cause for heart failure symptoms than a short LAVI with IACD were
implanted with pacemakers for left atrial permanent stimulation via the coro-
